nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—SLCO1B1—Conjugated Estrogens—osteoporosis	0.0785	0.11	CbGbCtD
Gemfibrozil—SLCO1B1—Estradiol—osteoporosis	0.0689	0.0965	CbGbCtD
Gemfibrozil—CYP1A2—Estropipate—osteoporosis	0.0544	0.0762	CbGbCtD
Gemfibrozil—CYP2C9—Estropipate—osteoporosis	0.049	0.0686	CbGbCtD
Gemfibrozil—CYP2C8—Raloxifene—osteoporosis	0.0469	0.0656	CbGbCtD
Gemfibrozil—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0453	0.0634	CbGbCtD
Gemfibrozil—CYP2C8—Cholecalciferol—osteoporosis	0.0362	0.0507	CbGbCtD
Gemfibrozil—CYP2C19—Cholecalciferol—osteoporosis	0.0304	0.0425	CbGbCtD
Gemfibrozil—CYP2C8—Estradiol—osteoporosis	0.0292	0.0409	CbGbCtD
Gemfibrozil—CYP3A4—Estropipate—osteoporosis	0.0285	0.0399	CbGbCtD
Gemfibrozil—CYP3A4—Calcitriol—osteoporosis	0.0285	0.0399	CbGbCtD
Gemfibrozil—CYP1A2—Conjugated Estrogens—osteoporosis	0.0257	0.036	CbGbCtD
Gemfibrozil—CYP2C9—Cholecalciferol—osteoporosis	0.0252	0.0354	CbGbCtD
Gemfibrozil—CYP2C19—Estradiol—osteoporosis	0.0245	0.0343	CbGbCtD
Gemfibrozil—CYP3A4—Ergocalciferol—osteoporosis	0.0228	0.0319	CbGbCtD
Gemfibrozil—CYP1A2—Estradiol—osteoporosis	0.0226	0.0316	CbGbCtD
Gemfibrozil—CYP2C9—Estradiol—osteoporosis	0.0203	0.0285	CbGbCtD
Gemfibrozil—CYP3A4—Raloxifene—osteoporosis	0.019	0.0266	CbGbCtD
Gemfibrozil—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0184	0.0257	CbGbCtD
Gemfibrozil—CYP3A4—Cholecalciferol—osteoporosis	0.0147	0.0206	CbGbCtD
Gemfibrozil—CYP3A4—Conjugated Estrogens—osteoporosis	0.0135	0.0189	CbGbCtD
Gemfibrozil—CYP3A4—Estradiol—osteoporosis	0.0118	0.0166	CbGbCtD
Gemfibrozil—Abdominal pain—Estropipate—osteoporosis	0.000332	0.00143	CcSEcCtD
Gemfibrozil—Feeling abnormal—Ibandronate—osteoporosis	0.000332	0.00143	CcSEcCtD
Gemfibrozil—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000331	0.00143	CcSEcCtD
Gemfibrozil—Nervousness—Conjugated Estrogens—osteoporosis	0.00033	0.00143	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Estradiol—osteoporosis	0.000329	0.00142	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Ibandronate—osteoporosis	0.000329	0.00142	CcSEcCtD
Gemfibrozil—Myalgia—Pamidronate—osteoporosis	0.000329	0.00142	CcSEcCtD
Gemfibrozil—Arthralgia—Pamidronate—osteoporosis	0.000329	0.00142	CcSEcCtD
Gemfibrozil—Urticaria—Alendronate—osteoporosis	0.000329	0.00142	CcSEcCtD
Gemfibrozil—Abdominal pain—Alendronate—osteoporosis	0.000327	0.00141	CcSEcCtD
Gemfibrozil—Shock—Risedronate—osteoporosis	0.000327	0.00141	CcSEcCtD
Gemfibrozil—Anaemia—Zoledronate—osteoporosis	0.000326	0.00141	CcSEcCtD
Gemfibrozil—Nervous system disorder—Risedronate—osteoporosis	0.000326	0.0014	CcSEcCtD
Gemfibrozil—Angioedema—Zoledronate—osteoporosis	0.000323	0.00139	CcSEcCtD
Gemfibrozil—Skin disorder—Risedronate—osteoporosis	0.000322	0.00139	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Calcitriol—osteoporosis	0.000322	0.00139	CcSEcCtD
Gemfibrozil—Abdominal pain—Raloxifene—osteoporosis	0.000322	0.00139	CcSEcCtD
Gemfibrozil—Vision blurred—Conjugated Estrogens—osteoporosis	0.000321	0.00138	CcSEcCtD
Gemfibrozil—Urticaria—Ibandronate—osteoporosis	0.00032	0.00138	CcSEcCtD
Gemfibrozil—Abdominal pain—Ibandronate—osteoporosis	0.000318	0.00137	CcSEcCtD
Gemfibrozil—Confusional state—Pamidronate—osteoporosis	0.000318	0.00137	CcSEcCtD
Gemfibrozil—Vertigo—Zoledronate—osteoporosis	0.000317	0.00137	CcSEcCtD
Gemfibrozil—Syncope—Zoledronate—osteoporosis	0.000317	0.00137	CcSEcCtD
Gemfibrozil—Leukopenia—Zoledronate—osteoporosis	0.000316	0.00136	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Pamidronate—osteoporosis	0.000316	0.00136	CcSEcCtD
Gemfibrozil—Oedema—Pamidronate—osteoporosis	0.000316	0.00136	CcSEcCtD
Gemfibrozil—Rhinitis—Estradiol—osteoporosis	0.000314	0.00135	CcSEcCtD
Gemfibrozil—Urticaria—Calcitriol—osteoporosis	0.000313	0.00135	CcSEcCtD
Gemfibrozil—Abdominal pain—Calcitriol—osteoporosis	0.000312	0.00135	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Estradiol—osteoporosis	0.000311	0.00134	CcSEcCtD
Gemfibrozil—Angioedema—Conjugated Estrogens—osteoporosis	0.000311	0.00134	CcSEcCtD
Gemfibrozil—Shock—Pamidronate—osteoporosis	0.000311	0.00134	CcSEcCtD
Gemfibrozil—Loss of consciousness—Zoledronate—osteoporosis	0.00031	0.00134	CcSEcCtD
Gemfibrozil—Nervous system disorder—Pamidronate—osteoporosis	0.00031	0.00134	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Pamidronate—osteoporosis	0.000309	0.00133	CcSEcCtD
Gemfibrozil—Vomiting—Etidronic acid—osteoporosis	0.000309	0.00133	CcSEcCtD
Gemfibrozil—Cough—Zoledronate—osteoporosis	0.000308	0.00133	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Estradiol—osteoporosis	0.000307	0.00133	CcSEcCtD
Gemfibrozil—Rash—Etidronic acid—osteoporosis	0.000306	0.00132	CcSEcCtD
Gemfibrozil—Convulsion—Zoledronate—osteoporosis	0.000306	0.00132	CcSEcCtD
Gemfibrozil—Dermatitis—Etidronic acid—osteoporosis	0.000306	0.00132	CcSEcCtD
Gemfibrozil—Vertigo—Conjugated Estrogens—osteoporosis	0.000306	0.00132	CcSEcCtD
Gemfibrozil—Syncope—Conjugated Estrogens—osteoporosis	0.000305	0.00132	CcSEcCtD
Gemfibrozil—Headache—Etidronic acid—osteoporosis	0.000304	0.00131	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000302	0.00131	CcSEcCtD
Gemfibrozil—Asthenia—Estropipate—osteoporosis	0.000301	0.0013	CcSEcCtD
Gemfibrozil—Myalgia—Zoledronate—osteoporosis	0.000301	0.0013	CcSEcCtD
Gemfibrozil—Chest pain—Zoledronate—osteoporosis	0.000301	0.0013	CcSEcCtD
Gemfibrozil—Arthralgia—Zoledronate—osteoporosis	0.000301	0.0013	CcSEcCtD
Gemfibrozil—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000299	0.00129	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000299	0.00129	CcSEcCtD
Gemfibrozil—Paraesthesia—Risedronate—osteoporosis	0.000298	0.00129	CcSEcCtD
Gemfibrozil—Pruritus—Estropipate—osteoporosis	0.000297	0.00128	CcSEcCtD
Gemfibrozil—Asthenia—Alendronate—osteoporosis	0.000297	0.00128	CcSEcCtD
Gemfibrozil—Cough—Conjugated Estrogens—osteoporosis	0.000297	0.00128	CcSEcCtD
Gemfibrozil—Convulsion—Conjugated Estrogens—osteoporosis	0.000295	0.00127	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000294	0.00127	CcSEcCtD
Gemfibrozil—Fatigue—Ethinyl Estradiol—osteoporosis	0.000294	0.00127	CcSEcCtD
Gemfibrozil—Pruritus—Alendronate—osteoporosis	0.000293	0.00126	CcSEcCtD
Gemfibrozil—Dyspepsia—Risedronate—osteoporosis	0.000292	0.00126	CcSEcCtD
Gemfibrozil—Eye disorder—Estradiol—osteoporosis	0.000292	0.00126	CcSEcCtD
Gemfibrozil—Constipation—Ethinyl Estradiol—osteoporosis	0.000291	0.00126	CcSEcCtD
Gemfibrozil—Confusional state—Zoledronate—osteoporosis	0.000291	0.00125	CcSEcCtD
Gemfibrozil—Myalgia—Conjugated Estrogens—osteoporosis	0.00029	0.00125	CcSEcCtD
Gemfibrozil—Chest pain—Conjugated Estrogens—osteoporosis	0.00029	0.00125	CcSEcCtD
Gemfibrozil—Arthralgia—Conjugated Estrogens—osteoporosis	0.00029	0.00125	CcSEcCtD
Gemfibrozil—Asthenia—Ibandronate—osteoporosis	0.000289	0.00125	CcSEcCtD
Gemfibrozil—Nausea—Etidronic acid—osteoporosis	0.000288	0.00124	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Zoledronate—osteoporosis	0.000288	0.00124	CcSEcCtD
Gemfibrozil—Oedema—Zoledronate—osteoporosis	0.000288	0.00124	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000288	0.00124	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000288	0.00124	CcSEcCtD
Gemfibrozil—Diarrhoea—Estropipate—osteoporosis	0.000287	0.00124	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Risedronate—osteoporosis	0.000287	0.00124	CcSEcCtD
Gemfibrozil—Fatigue—Risedronate—osteoporosis	0.000286	0.00124	CcSEcCtD
Gemfibrozil—Pruritus—Ibandronate—osteoporosis	0.000285	0.00123	CcSEcCtD
Gemfibrozil—Pain—Risedronate—osteoporosis	0.000284	0.00123	CcSEcCtD
Gemfibrozil—Constipation—Risedronate—osteoporosis	0.000284	0.00123	CcSEcCtD
Gemfibrozil—Shock—Zoledronate—osteoporosis	0.000284	0.00122	CcSEcCtD
Gemfibrozil—Paraesthesia—Pamidronate—osteoporosis	0.000283	0.00122	CcSEcCtD
Gemfibrozil—Diarrhoea—Alendronate—osteoporosis	0.000283	0.00122	CcSEcCtD
Gemfibrozil—Asthenia—Calcitriol—osteoporosis	0.000283	0.00122	CcSEcCtD
Gemfibrozil—Nervous system disorder—Zoledronate—osteoporosis	0.000283	0.00122	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Zoledronate—osteoporosis	0.000282	0.00122	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Estradiol—osteoporosis	0.000282	0.00122	CcSEcCtD
Gemfibrozil—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000281	0.00121	CcSEcCtD
Gemfibrozil—Somnolence—Pamidronate—osteoporosis	0.000281	0.00121	CcSEcCtD
Gemfibrozil—Skin disorder—Zoledronate—osteoporosis	0.00028	0.00121	CcSEcCtD
Gemfibrozil—Pruritus—Calcitriol—osteoporosis	0.000279	0.0012	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000278	0.0012	CcSEcCtD
Gemfibrozil—Diarrhoea—Raloxifene—osteoporosis	0.000278	0.0012	CcSEcCtD
Gemfibrozil—Dyspepsia—Pamidronate—osteoporosis	0.000278	0.0012	CcSEcCtD
Gemfibrozil—Dizziness—Estropipate—osteoporosis	0.000278	0.0012	CcSEcCtD
Gemfibrozil—Oedema—Conjugated Estrogens—osteoporosis	0.000278	0.0012	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000278	0.0012	CcSEcCtD
Gemfibrozil—Alopecia—Estradiol—osteoporosis	0.000276	0.00119	CcSEcCtD
Gemfibrozil—Diarrhoea—Ibandronate—osteoporosis	0.000276	0.00119	CcSEcCtD
Gemfibrozil—Mental disorder—Estradiol—osteoporosis	0.000274	0.00118	CcSEcCtD
Gemfibrozil—Dizziness—Alendronate—osteoporosis	0.000274	0.00118	CcSEcCtD
Gemfibrozil—Shock—Conjugated Estrogens—osteoporosis	0.000273	0.00118	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000272	0.00118	CcSEcCtD
Gemfibrozil—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000272	0.00117	CcSEcCtD
Gemfibrozil—Fatigue—Pamidronate—osteoporosis	0.000272	0.00117	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Risedronate—osteoporosis	0.000271	0.00117	CcSEcCtD
Gemfibrozil—Urticaria—Ethinyl Estradiol—osteoporosis	0.000271	0.00117	CcSEcCtD
Gemfibrozil—Pain—Pamidronate—osteoporosis	0.00027	0.00116	CcSEcCtD
Gemfibrozil—Constipation—Pamidronate—osteoporosis	0.00027	0.00116	CcSEcCtD
Gemfibrozil—Diarrhoea—Calcitriol—osteoporosis	0.00027	0.00116	CcSEcCtD
Gemfibrozil—Skin disorder—Conjugated Estrogens—osteoporosis	0.00027	0.00116	CcSEcCtD
Gemfibrozil—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000269	0.00116	CcSEcCtD
Gemfibrozil—Dizziness—Raloxifene—osteoporosis	0.000269	0.00116	CcSEcCtD
Gemfibrozil—Flatulence—Estradiol—osteoporosis	0.000268	0.00116	CcSEcCtD
Gemfibrozil—Tension—Estradiol—osteoporosis	0.000267	0.00115	CcSEcCtD
Gemfibrozil—Vomiting—Estropipate—osteoporosis	0.000267	0.00115	CcSEcCtD
Gemfibrozil—Dysgeusia—Estradiol—osteoporosis	0.000267	0.00115	CcSEcCtD
Gemfibrozil—Dizziness—Ibandronate—osteoporosis	0.000266	0.00115	CcSEcCtD
Gemfibrozil—Rash—Estropipate—osteoporosis	0.000265	0.00114	CcSEcCtD
Gemfibrozil—Dermatitis—Estropipate—osteoporosis	0.000265	0.00114	CcSEcCtD
Gemfibrozil—Nervousness—Estradiol—osteoporosis	0.000264	0.00114	CcSEcCtD
Gemfibrozil—Urticaria—Risedronate—osteoporosis	0.000264	0.00114	CcSEcCtD
Gemfibrozil—Headache—Estropipate—osteoporosis	0.000263	0.00114	CcSEcCtD
Gemfibrozil—Vomiting—Alendronate—osteoporosis	0.000263	0.00114	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000263	0.00113	CcSEcCtD
Gemfibrozil—Abdominal pain—Risedronate—osteoporosis	0.000262	0.00113	CcSEcCtD
Gemfibrozil—Rash—Alendronate—osteoporosis	0.000261	0.00113	CcSEcCtD
Gemfibrozil—Dermatitis—Alendronate—osteoporosis	0.000261	0.00112	CcSEcCtD
Gemfibrozil—Feeling abnormal—Pamidronate—osteoporosis	0.00026	0.00112	CcSEcCtD
Gemfibrozil—Headache—Alendronate—osteoporosis	0.000259	0.00112	CcSEcCtD
Gemfibrozil—Paraesthesia—Zoledronate—osteoporosis	0.000259	0.00112	CcSEcCtD
Gemfibrozil—Vomiting—Raloxifene—osteoporosis	0.000259	0.00112	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Pamidronate—osteoporosis	0.000258	0.00111	CcSEcCtD
Gemfibrozil—Rash—Raloxifene—osteoporosis	0.000257	0.00111	CcSEcCtD
Gemfibrozil—Dermatitis—Raloxifene—osteoporosis	0.000256	0.00111	CcSEcCtD
Gemfibrozil—Somnolence—Zoledronate—osteoporosis	0.000256	0.00111	CcSEcCtD
Gemfibrozil—Vomiting—Ibandronate—osteoporosis	0.000256	0.00111	CcSEcCtD
Gemfibrozil—Headache—Raloxifene—osteoporosis	0.000255	0.0011	CcSEcCtD
Gemfibrozil—Rash—Ibandronate—osteoporosis	0.000254	0.0011	CcSEcCtD
Gemfibrozil—Dermatitis—Ibandronate—osteoporosis	0.000254	0.0011	CcSEcCtD
Gemfibrozil—Dyspepsia—Zoledronate—osteoporosis	0.000254	0.0011	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000253	0.00109	CcSEcCtD
Gemfibrozil—Headache—Ibandronate—osteoporosis	0.000252	0.00109	CcSEcCtD
Gemfibrozil—Vomiting—Calcitriol—osteoporosis	0.000251	0.00108	CcSEcCtD
Gemfibrozil—Nausea—Estropipate—osteoporosis	0.00025	0.00108	CcSEcCtD
Gemfibrozil—Abdominal pain—Pamidronate—osteoporosis	0.00025	0.00108	CcSEcCtD
Gemfibrozil—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000249	0.00108	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000249	0.00107	CcSEcCtD
Gemfibrozil—Angioedema—Estradiol—osteoporosis	0.000249	0.00107	CcSEcCtD
Gemfibrozil—Rash—Calcitriol—osteoporosis	0.000249	0.00107	CcSEcCtD
Gemfibrozil—Fatigue—Zoledronate—osteoporosis	0.000249	0.00107	CcSEcCtD
Gemfibrozil—Dermatitis—Calcitriol—osteoporosis	0.000248	0.00107	CcSEcCtD
Gemfibrozil—Headache—Calcitriol—osteoporosis	0.000247	0.00107	CcSEcCtD
Gemfibrozil—Somnolence—Conjugated Estrogens—osteoporosis	0.000247	0.00106	CcSEcCtD
Gemfibrozil—Pain—Zoledronate—osteoporosis	0.000247	0.00106	CcSEcCtD
Gemfibrozil—Constipation—Zoledronate—osteoporosis	0.000247	0.00106	CcSEcCtD
Gemfibrozil—Nausea—Alendronate—osteoporosis	0.000246	0.00106	CcSEcCtD
Gemfibrozil—Vertigo—Estradiol—osteoporosis	0.000245	0.00106	CcSEcCtD
Gemfibrozil—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000244	0.00105	CcSEcCtD
Gemfibrozil—Asthenia—Ethinyl Estradiol—osteoporosis	0.000244	0.00105	CcSEcCtD
Gemfibrozil—Syncope—Estradiol—osteoporosis	0.000244	0.00105	CcSEcCtD
Gemfibrozil—Nausea—Raloxifene—osteoporosis	0.000242	0.00104	CcSEcCtD
Gemfibrozil—Pruritus—Ethinyl Estradiol—osteoporosis	0.000241	0.00104	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00024	0.00103	CcSEcCtD
Gemfibrozil—Fatigue—Conjugated Estrogens—osteoporosis	0.000239	0.00103	CcSEcCtD
Gemfibrozil—Nausea—Ibandronate—osteoporosis	0.000239	0.00103	CcSEcCtD
Gemfibrozil—Loss of consciousness—Estradiol—osteoporosis	0.000239	0.00103	CcSEcCtD
Gemfibrozil—Asthenia—Risedronate—osteoporosis	0.000238	0.00103	CcSEcCtD
Gemfibrozil—Feeling abnormal—Zoledronate—osteoporosis	0.000238	0.00103	CcSEcCtD
Gemfibrozil—Cough—Estradiol—osteoporosis	0.000238	0.00103	CcSEcCtD
Gemfibrozil—Constipation—Conjugated Estrogens—osteoporosis	0.000237	0.00102	CcSEcCtD
Gemfibrozil—Pain—Conjugated Estrogens—osteoporosis	0.000237	0.00102	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Zoledronate—osteoporosis	0.000236	0.00102	CcSEcCtD
Gemfibrozil—Pruritus—Risedronate—osteoporosis	0.000235	0.00101	CcSEcCtD
Gemfibrozil—Nausea—Calcitriol—osteoporosis	0.000234	0.00101	CcSEcCtD
Gemfibrozil—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000233	0.00101	CcSEcCtD
Gemfibrozil—Myalgia—Estradiol—osteoporosis	0.000232	0.001	CcSEcCtD
Gemfibrozil—Arthralgia—Estradiol—osteoporosis	0.000232	0.001	CcSEcCtD
Gemfibrozil—Chest pain—Estradiol—osteoporosis	0.000232	0.001	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.00023	0.000993	CcSEcCtD
Gemfibrozil—Urticaria—Zoledronate—osteoporosis	0.000229	0.000988	CcSEcCtD
Gemfibrozil—Abdominal pain—Zoledronate—osteoporosis	0.000228	0.000983	CcSEcCtD
Gemfibrozil—Diarrhoea—Risedronate—osteoporosis	0.000227	0.00098	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000227	0.000979	CcSEcCtD
Gemfibrozil—Asthenia—Pamidronate—osteoporosis	0.000226	0.000977	CcSEcCtD
Gemfibrozil—Dizziness—Ethinyl Estradiol—osteoporosis	0.000225	0.000972	CcSEcCtD
Gemfibrozil—Confusional state—Estradiol—osteoporosis	0.000224	0.000967	CcSEcCtD
Gemfibrozil—Pruritus—Pamidronate—osteoporosis	0.000223	0.000964	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Estradiol—osteoporosis	0.000222	0.000959	CcSEcCtD
Gemfibrozil—Oedema—Estradiol—osteoporosis	0.000222	0.000959	CcSEcCtD
Gemfibrozil—Urticaria—Conjugated Estrogens—osteoporosis	0.000221	0.000952	CcSEcCtD
Gemfibrozil—Dizziness—Risedronate—osteoporosis	0.00022	0.000947	CcSEcCtD
Gemfibrozil—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000219	0.000947	CcSEcCtD
Gemfibrozil—Shock—Estradiol—osteoporosis	0.000219	0.000943	CcSEcCtD
Gemfibrozil—Nervous system disorder—Estradiol—osteoporosis	0.000218	0.00094	CcSEcCtD
Gemfibrozil—Vomiting—Ethinyl Estradiol—osteoporosis	0.000217	0.000934	CcSEcCtD
Gemfibrozil—Diarrhoea—Pamidronate—osteoporosis	0.000216	0.000932	CcSEcCtD
Gemfibrozil—Skin disorder—Estradiol—osteoporosis	0.000216	0.000931	CcSEcCtD
Gemfibrozil—Rash—Ethinyl Estradiol—osteoporosis	0.000215	0.000926	CcSEcCtD
Gemfibrozil—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000215	0.000926	CcSEcCtD
Gemfibrozil—Headache—Ethinyl Estradiol—osteoporosis	0.000213	0.000921	CcSEcCtD
Gemfibrozil—Vomiting—Risedronate—osteoporosis	0.000211	0.000911	CcSEcCtD
Gemfibrozil—Rash—Risedronate—osteoporosis	0.000209	0.000903	CcSEcCtD
Gemfibrozil—Dermatitis—Risedronate—osteoporosis	0.000209	0.000902	CcSEcCtD
Gemfibrozil—Dizziness—Pamidronate—osteoporosis	0.000209	0.000901	CcSEcCtD
Gemfibrozil—Headache—Risedronate—osteoporosis	0.000208	0.000897	CcSEcCtD
Gemfibrozil—Asthenia—Zoledronate—osteoporosis	0.000207	0.000893	CcSEcCtD
Gemfibrozil—Pruritus—Zoledronate—osteoporosis	0.000204	0.00088	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000202	0.000873	CcSEcCtD
Gemfibrozil—Nausea—Ethinyl Estradiol—osteoporosis	0.000202	0.000873	CcSEcCtD
Gemfibrozil—Vomiting—Pamidronate—osteoporosis	0.000201	0.000866	CcSEcCtD
Gemfibrozil—Paraesthesia—Estradiol—osteoporosis	0.000199	0.000861	CcSEcCtD
Gemfibrozil—Asthenia—Conjugated Estrogens—osteoporosis	0.000199	0.000859	CcSEcCtD
Gemfibrozil—Rash—Pamidronate—osteoporosis	0.000199	0.000859	CcSEcCtD
Gemfibrozil—Dermatitis—Pamidronate—osteoporosis	0.000199	0.000858	CcSEcCtD
Gemfibrozil—Headache—Pamidronate—osteoporosis	0.000198	0.000853	CcSEcCtD
Gemfibrozil—Somnolence—Estradiol—osteoporosis	0.000198	0.000852	CcSEcCtD
Gemfibrozil—Diarrhoea—Zoledronate—osteoporosis	0.000197	0.000851	CcSEcCtD
Gemfibrozil—Nausea—Risedronate—osteoporosis	0.000197	0.000851	CcSEcCtD
Gemfibrozil—Pruritus—Conjugated Estrogens—osteoporosis	0.000196	0.000847	CcSEcCtD
Gemfibrozil—Dyspepsia—Estradiol—osteoporosis	0.000196	0.000844	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Estradiol—osteoporosis	0.000192	0.000828	CcSEcCtD
Gemfibrozil—Fatigue—Estradiol—osteoporosis	0.000192	0.000827	CcSEcCtD
Gemfibrozil—Dizziness—Zoledronate—osteoporosis	0.000191	0.000823	CcSEcCtD
Gemfibrozil—Constipation—Estradiol—osteoporosis	0.00019	0.00082	CcSEcCtD
Gemfibrozil—Pain—Estradiol—osteoporosis	0.00019	0.00082	CcSEcCtD
Gemfibrozil—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00019	0.00082	CcSEcCtD
Gemfibrozil—Nausea—Pamidronate—osteoporosis	0.000187	0.000809	CcSEcCtD
Gemfibrozil—Dizziness—Conjugated Estrogens—osteoporosis	0.000184	0.000792	CcSEcCtD
Gemfibrozil—Vomiting—Zoledronate—osteoporosis	0.000183	0.000791	CcSEcCtD
Gemfibrozil—Feeling abnormal—Estradiol—osteoporosis	0.000183	0.00079	CcSEcCtD
Gemfibrozil—Rash—Zoledronate—osteoporosis	0.000182	0.000784	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Estradiol—osteoporosis	0.000182	0.000784	CcSEcCtD
Gemfibrozil—Dermatitis—Zoledronate—osteoporosis	0.000182	0.000784	CcSEcCtD
Gemfibrozil—Headache—Zoledronate—osteoporosis	0.000181	0.000779	CcSEcCtD
Gemfibrozil—Vomiting—Conjugated Estrogens—osteoporosis	0.000177	0.000762	CcSEcCtD
Gemfibrozil—Urticaria—Estradiol—osteoporosis	0.000176	0.000762	CcSEcCtD
Gemfibrozil—Abdominal pain—Estradiol—osteoporosis	0.000176	0.000758	CcSEcCtD
Gemfibrozil—Rash—Conjugated Estrogens—osteoporosis	0.000175	0.000755	CcSEcCtD
Gemfibrozil—Dermatitis—Conjugated Estrogens—osteoporosis	0.000175	0.000755	CcSEcCtD
Gemfibrozil—Headache—Conjugated Estrogens—osteoporosis	0.000174	0.00075	CcSEcCtD
Gemfibrozil—Nausea—Zoledronate—osteoporosis	0.000171	0.000739	CcSEcCtD
Gemfibrozil—Nausea—Conjugated Estrogens—osteoporosis	0.000165	0.000711	CcSEcCtD
Gemfibrozil—Asthenia—Estradiol—osteoporosis	0.000159	0.000688	CcSEcCtD
Gemfibrozil—Pruritus—Estradiol—osteoporosis	0.000157	0.000678	CcSEcCtD
Gemfibrozil—Diarrhoea—Estradiol—osteoporosis	0.000152	0.000656	CcSEcCtD
Gemfibrozil—Dizziness—Estradiol—osteoporosis	0.000147	0.000634	CcSEcCtD
Gemfibrozil—Vomiting—Estradiol—osteoporosis	0.000141	0.00061	CcSEcCtD
Gemfibrozil—Rash—Estradiol—osteoporosis	0.00014	0.000604	CcSEcCtD
Gemfibrozil—Dermatitis—Estradiol—osteoporosis	0.00014	0.000604	CcSEcCtD
Gemfibrozil—Headache—Estradiol—osteoporosis	0.000139	0.000601	CcSEcCtD
Gemfibrozil—Nausea—Estradiol—osteoporosis	0.000132	0.000569	CcSEcCtD
Gemfibrozil—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000104	0.00192	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000102	0.00188	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.0001	0.00185	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	9.64e-05	0.00177	CbGpPWpGaD
Gemfibrozil—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	9.64e-05	0.00177	CbGpPWpGaD
Gemfibrozil—CYP2C8—Phase 1 - Functionalization of compounds—POMC—osteoporosis	9.6e-05	0.00177	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	9.18e-05	0.00169	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	9.14e-05	0.00168	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—IDH2—osteoporosis	9.06e-05	0.00167	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	8.79e-05	0.00162	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	8.67e-05	0.0016	CbGpPWpGaD
Gemfibrozil—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	8.57e-05	0.00158	CbGpPWpGaD
Gemfibrozil—CYP2C19—Phase 1 - Functionalization of compounds—POMC—osteoporosis	8.57e-05	0.00158	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	8.55e-05	0.00157	CbGpPWpGaD
Gemfibrozil—PPARA—Adipogenesis—IL6—osteoporosis	8.55e-05	0.00157	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—CYP27A1—osteoporosis	8.52e-05	0.00157	CbGpPWpGaD
Gemfibrozil—CYP2C8—Biological oxidations—CYP19A1—osteoporosis	8.48e-05	0.00156	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PKM—osteoporosis	8.37e-05	0.00154	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—FDPS—osteoporosis	8.37e-05	0.00154	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metapathway biotransformation—CYP19A1—osteoporosis	8.37e-05	0.00154	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	8.33e-05	0.00153	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—ACP5—osteoporosis	8.29e-05	0.00153	CbGpPWpGaD
Gemfibrozil—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	8.24e-05	0.00152	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	8.18e-05	0.00151	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—ESR1—osteoporosis	7.98e-05	0.00147	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	7.96e-05	0.00147	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PGLS—osteoporosis	7.93e-05	0.00146	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GPD2—osteoporosis	7.93e-05	0.00146	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—LEP—osteoporosis	7.87e-05	0.00145	CbGpPWpGaD
Gemfibrozil—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	7.81e-05	0.00144	CbGpPWpGaD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—ADCY5—osteoporosis	7.81e-05	0.00144	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	7.76e-05	0.00143	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—TPI1—osteoporosis	7.7e-05	0.00142	CbGpPWpGaD
Gemfibrozil—CYP2C19—Biological oxidations—CYP19A1—osteoporosis	7.57e-05	0.00139	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	7.56e-05	0.00139	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	7.51e-05	0.00138	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metapathway biotransformation—CYP19A1—osteoporosis	7.47e-05	0.00138	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—ATIC—osteoporosis	7.26e-05	0.00134	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PNP—osteoporosis	7.26e-05	0.00134	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—P4HB—osteoporosis	7.24e-05	0.00133	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	7.12e-05	0.00131	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—GAPDH—osteoporosis	7.11e-05	0.00131	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	7.11e-05	0.00131	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—PSMA2—osteoporosis	7.09e-05	0.00131	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—PSMA5—osteoporosis	7.09e-05	0.00131	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	6.92e-05	0.00127	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—RAP1A—osteoporosis	6.92e-05	0.00127	CbGpPWpGaD
Gemfibrozil—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	6.91e-05	0.00127	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	6.81e-05	0.00125	CbGpPWpGaD
Gemfibrozil—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	6.68e-05	0.00123	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—IL6R—osteoporosis	6.6e-05	0.00121	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	6.48e-05	0.00119	CbGpPWpGaD
Gemfibrozil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	6.36e-05	0.00117	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—ESR2—osteoporosis	6.34e-05	0.00117	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	6.31e-05	0.00116	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	6.2e-05	0.00114	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—OXCT1—osteoporosis	6.17e-05	0.00114	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CA2—osteoporosis	6.17e-05	0.00114	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6.04e-05	0.00111	CbGpPWpGaD
Gemfibrozil—PPARA—Circadian rythm related genes—IL6—osteoporosis	6.03e-05	0.00111	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—MGLL—osteoporosis	6.01e-05	0.00111	CbGpPWpGaD
Gemfibrozil—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	5.9e-05	0.00109	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	5.89e-05	0.00108	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	5.87e-05	0.00108	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	5.82e-05	0.00107	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.67e-05	0.00104	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—ENO1—osteoporosis	5.6e-05	0.00103	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	5.54e-05	0.00102	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	5.54e-05	0.00102	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PSMA2—osteoporosis	5.52e-05	0.00102	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PSMA5—osteoporosis	5.52e-05	0.00102	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	5.48e-05	0.00101	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	5.48e-05	0.00101	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	5.4e-05	0.000993	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	5.27e-05	0.000971	CbGpPWpGaD
Gemfibrozil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	5.15e-05	0.000949	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—IDH2—osteoporosis	5.11e-05	0.000941	CbGpPWpGaD
Gemfibrozil—CYP2C8—Biological oxidations—POMC—osteoporosis	5.1e-05	0.000939	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	5.05e-05	0.000929	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—VDR—osteoporosis	5.03e-05	0.000926	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PKM—osteoporosis	4.81e-05	0.000885	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—FDPS—osteoporosis	4.81e-05	0.000885	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CYP27A1—osteoporosis	4.81e-05	0.000885	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.71e-05	0.000867	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—ACP5—osteoporosis	4.68e-05	0.000861	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.62e-05	0.00085	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GPD2—osteoporosis	4.56e-05	0.000839	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PGLS—osteoporosis	4.56e-05	0.000839	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	4.55e-05	0.000838	CbGpPWpGaD
Gemfibrozil—CYP2C19—Biological oxidations—POMC—osteoporosis	4.55e-05	0.000838	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	4.49e-05	0.000827	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—CYP19A1—osteoporosis	4.47e-05	0.000824	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.4e-05	0.000811	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—TPI1—osteoporosis	4.35e-05	0.0008	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.31e-05	0.000794	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PKM—osteoporosis	4.29e-05	0.00079	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—FDPS—osteoporosis	4.29e-05	0.00079	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.29e-05	0.00079	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PNP—osteoporosis	4.17e-05	0.000768	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ATIC—osteoporosis	4.17e-05	0.000768	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—MYC—osteoporosis	4.15e-05	0.000764	CbGpPWpGaD
Gemfibrozil—CYP2C9—Biological oxidations—POMC—osteoporosis	4.15e-05	0.000764	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—P4HB—osteoporosis	4.09e-05	0.000752	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PGLS—osteoporosis	4.07e-05	0.000749	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GPD2—osteoporosis	4.07e-05	0.000749	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GAPDH—osteoporosis	4.01e-05	0.000739	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—FDPS—osteoporosis	3.91e-05	0.000721	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PKM—osteoporosis	3.91e-05	0.000721	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—RAP1A—osteoporosis	3.91e-05	0.000719	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—TGFB1—osteoporosis	3.9e-05	0.000718	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—ESR1—osteoporosis	3.84e-05	0.000708	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PNP—osteoporosis	3.72e-05	0.000685	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ATIC—osteoporosis	3.72e-05	0.000685	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PGLS—osteoporosis	3.71e-05	0.000683	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GPD2—osteoporosis	3.71e-05	0.000683	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.67e-05	0.000675	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—ADCY5—osteoporosis	3.66e-05	0.000673	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—GPX1—osteoporosis	3.64e-05	0.000671	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—TNF—osteoporosis	3.64e-05	0.00067	CbGpPWpGaD
Gemfibrozil—CYP1A2—Biological oxidations—POMC—osteoporosis	3.55e-05	0.000653	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—OXCT1—osteoporosis	3.55e-05	0.000653	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CA2—osteoporosis	3.55e-05	0.000653	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—MGLL—osteoporosis	3.46e-05	0.000636	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.41e-05	0.000627	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ATIC—osteoporosis	3.39e-05	0.000625	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PNP—osteoporosis	3.39e-05	0.000625	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—MTHFR—osteoporosis	3.36e-05	0.000619	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PKM—osteoporosis	3.34e-05	0.000616	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—FDPS—osteoporosis	3.34e-05	0.000616	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.26e-05	0.0006	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PGLS—osteoporosis	3.17e-05	0.000584	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GPD2—osteoporosis	3.17e-05	0.000584	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—OXCT1—osteoporosis	3.16e-05	0.000583	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CA2—osteoporosis	3.16e-05	0.000583	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—ENO1—osteoporosis	3.16e-05	0.000581	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PSMA2—osteoporosis	3.11e-05	0.000573	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PSMA5—osteoporosis	3.11e-05	0.000573	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—MGLL—osteoporosis	3.08e-05	0.000568	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—IL6—osteoporosis	2.94e-05	0.000541	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—IDH2—osteoporosis	2.94e-05	0.000541	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.91e-05	0.000535	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ATIC—osteoporosis	2.9e-05	0.000534	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PNP—osteoporosis	2.9e-05	0.000534	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—OXCT1—osteoporosis	2.89e-05	0.000531	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CA2—osteoporosis	2.89e-05	0.000531	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—MGLL—osteoporosis	2.81e-05	0.000518	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP27A1—osteoporosis	2.76e-05	0.000509	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—POMC—osteoporosis	2.74e-05	0.000504	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—POMC—osteoporosis	2.69e-05	0.000495	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ACP5—osteoporosis	2.69e-05	0.000495	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.65e-05	0.000488	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.65e-05	0.000488	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—IDH2—osteoporosis	2.62e-05	0.000483	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PKM—osteoporosis	2.58e-05	0.000475	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—FDPS—osteoporosis	2.58e-05	0.000475	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CYP19A1—osteoporosis	2.53e-05	0.000465	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—TPI1—osteoporosis	2.5e-05	0.00046	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CA2—osteoporosis	2.47e-05	0.000454	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—OXCT1—osteoporosis	2.47e-05	0.000454	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP27A1—osteoporosis	2.47e-05	0.000454	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PGLS—osteoporosis	2.45e-05	0.000451	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GPD2—osteoporosis	2.45e-05	0.000451	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—MGLL—osteoporosis	2.4e-05	0.000442	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ACP5—osteoporosis	2.4e-05	0.000442	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—IDH2—osteoporosis	2.39e-05	0.00044	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.37e-05	0.000436	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—P4HB—osteoporosis	2.35e-05	0.000432	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GAPDH—osteoporosis	2.31e-05	0.000424	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.27e-05	0.000417	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP27A1—osteoporosis	2.25e-05	0.000414	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—RAP1A—osteoporosis	2.25e-05	0.000413	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ATIC—osteoporosis	2.24e-05	0.000412	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PNP—osteoporosis	2.24e-05	0.000412	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—TPI1—osteoporosis	2.23e-05	0.00041	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ACP5—osteoporosis	2.19e-05	0.000403	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.16e-05	0.000397	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—P4HB—osteoporosis	2.1e-05	0.000386	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—ADCY5—osteoporosis	2.06e-05	0.00038	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GAPDH—osteoporosis	2.06e-05	0.000379	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GPX1—osteoporosis	2.06e-05	0.000379	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—IDH2—osteoporosis	2.04e-05	0.000376	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—TPI1—osteoporosis	2.03e-05	0.000374	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—RAP1A—osteoporosis	2e-05	0.000369	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—MYC—osteoporosis	2e-05	0.000368	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.96e-05	0.00036	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP27A1—osteoporosis	1.92e-05	0.000354	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—P4HB—osteoporosis	1.91e-05	0.000352	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—OXCT1—osteoporosis	1.9e-05	0.00035	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CA2—osteoporosis	1.9e-05	0.00035	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—MTHFR—osteoporosis	1.9e-05	0.000349	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GAPDH—osteoporosis	1.88e-05	0.000345	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ACP5—osteoporosis	1.87e-05	0.000344	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—MGLL—osteoporosis	1.85e-05	0.000341	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.85e-05	0.00034	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—RAP1A—osteoporosis	1.83e-05	0.000336	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ENO1—osteoporosis	1.81e-05	0.000334	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PSMA5—osteoporosis	1.79e-05	0.000329	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PSMA2—osteoporosis	1.79e-05	0.000329	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.75e-05	0.000322	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—TPI1—osteoporosis	1.74e-05	0.00032	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—P4HB—osteoporosis	1.63e-05	0.000301	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ENO1—osteoporosis	1.62e-05	0.000298	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GAPDH—osteoporosis	1.6e-05	0.000295	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PSMA5—osteoporosis	1.6e-05	0.000294	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PSMA2—osteoporosis	1.6e-05	0.000294	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.59e-05	0.000293	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—IDH2—osteoporosis	1.58e-05	0.00029	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—RAP1A—osteoporosis	1.56e-05	0.000287	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—POMC—osteoporosis	1.52e-05	0.000279	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.48e-05	0.000273	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ENO1—osteoporosis	1.48e-05	0.000272	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PSMA5—osteoporosis	1.46e-05	0.000268	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PSMA2—osteoporosis	1.46e-05	0.000268	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP19A1—osteoporosis	1.45e-05	0.000267	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ACP5—osteoporosis	1.44e-05	0.000266	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.36e-05	0.000251	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—TPI1—osteoporosis	1.34e-05	0.000247	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP19A1—osteoporosis	1.3e-05	0.000238	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ENO1—osteoporosis	1.26e-05	0.000232	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—P4HB—osteoporosis	1.26e-05	0.000232	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PSMA2—osteoporosis	1.24e-05	0.000229	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PSMA5—osteoporosis	1.24e-05	0.000229	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GAPDH—osteoporosis	1.24e-05	0.000228	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—RAP1A—osteoporosis	1.21e-05	0.000222	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ADCY5—osteoporosis	1.19e-05	0.000218	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GPX1—osteoporosis	1.18e-05	0.000218	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP19A1—osteoporosis	1.18e-05	0.000217	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—MTHFR—osteoporosis	1.09e-05	0.000201	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ADCY5—osteoporosis	1.06e-05	0.000195	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GPX1—osteoporosis	1.05e-05	0.000194	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP19A1—osteoporosis	1.01e-05	0.000186	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ENO1—osteoporosis	9.74e-06	0.000179	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—MTHFR—osteoporosis	9.73e-06	0.000179	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ADCY5—osteoporosis	9.65e-06	0.000178	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GPX1—osteoporosis	9.62e-06	0.000177	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PSMA2—osteoporosis	9.6e-06	0.000177	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PSMA5—osteoporosis	9.6e-06	0.000177	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—MTHFR—osteoporosis	8.87e-06	0.000163	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—POMC—osteoporosis	8.72e-06	0.000161	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ADCY5—osteoporosis	8.25e-06	0.000152	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GPX1—osteoporosis	8.22e-06	0.000151	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP19A1—osteoporosis	7.79e-06	0.000143	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—POMC—osteoporosis	7.78e-06	0.000143	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—MTHFR—osteoporosis	7.58e-06	0.00014	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—POMC—osteoporosis	7.1e-06	0.000131	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ADCY5—osteoporosis	6.36e-06	0.000117	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GPX1—osteoporosis	6.34e-06	0.000117	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—POMC—osteoporosis	6.06e-06	0.000112	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—MTHFR—osteoporosis	5.85e-06	0.000108	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—POMC—osteoporosis	4.68e-06	8.62e-05	CbGpPWpGaD
